Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side Effects.

Hamidi, Sarah; Boucher, Andrée; Lemieux, Bernard; Rondeau, Geneviève; LebÅuf, Rebecca; Ste-Marie, Louis-Georges; Le, Xuan Kim; Mircescu, Hortensia

Hamidi, Sarah; Boucher, Andrée; Lemieux, Bernard; Rondeau, Geneviève; LebÅuf, Rebecca; Ste-Marie, Louis-Georges; Le, Xuan Kim; Mircescu, Hortensia.

Afiliação

Hamidi S; Division of Endocrinology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X0C1, Canada.
Boucher A; Division of Endocrinology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X0C1, Canada.
Lemieux B; Division of Medical Oncology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X0C1, Canada.
Rondeau G; Division of Endocrinology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X0C1, Canada.
LebÅuf R; Division of Endocrinology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X0C1, Canada.
Ste-Marie LG; Division of Endocrinology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X0C1, Canada.
Le XK; Division of Medical Oncology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X0C1, Canada.
Mircescu H; Division of Endocrinology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X0C1, Canada.

J Endocr Soc ; 6(6): bvac048, 2022 Jun 01.

Article em En | MEDLINE | ID: mdl-35475024

Palavras-chave

advanced differentiated thyroid cancer; adverse events; efficacy; lenvatinib; real-life data

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: J Endocr Soc Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá